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Background/aims: Charcot foot is a rare but devastating complication of diabetes. Little research is available on
the mental health impact of Charcot foot. Aim of the study is to assess mental health in diabetes patients with
Charcot foot and to investigate the moderating effects of socio-demographic factors. The severity of the problem
will be statistically evaluated with the help of a reference data set.
Methods: Cross-sectional questionnaire data using the Hospital Anxiety and Depression Scale (HADS) and
demographic background were collected from 50 patients with diabetes and Charcot complications (males 62%;
mean age 62.2 ± 8.5 years). Statistical comparisons with a large data set of general diabetes patients acting as a
point of reference were carried out.
Results: Anxiety and depression levels were high, (anxiety and depression scores 6.4 ± 4 and 6.3 ± 3.6 respectively).
Females reported more severe anxiety and depression. Ethnic minorities and patients out of work reported more
severe anxiety. Comparisons with published HADS data indicate that diabetes patients with Charcot foot experience
more serious levels of anxiety and depression.
Conclusions: The high levels of mental health problems which were found in this study in diabetes patients with
Charcot foot require recognition by researchers and clinicians. The findings imply the need to screen for mental
health problems in diabetes patients with Charcot foot.
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Charcot foot is a rare but potentially devastating compli-
cation of diabetes mellitus [1]. Despite an extensive lit-
erature linking diabetes and psychological morbidity, the
clinical management of diabetic foot problems does not
focus on psychological issues.
Charcot foot, also known as ‘neuroarthropathy/neuro-
pathic osteoarthropathy’, ‘Charcot joint’ [2] or ‘neurogenic
osteoarthropathy’ [3], is a disease of bone that is chronic
and progressive, and results in destruction of joints or
bones which have lost sensation [2]. Loss of protective
sensory innervation causes neuropathic changes which
can render the condition either painful or painless [4]. No
universally accepted criteria for the diagnosis of Charcot
foot are available [5]. Patients may present with inflamma-
tion of the foot or ankle [6] which may have been* Correspondence: Zahra.chapman@bartshealth.nhs.uk
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reproduction in any medium, provided the ortriggered by traumatic injury despite no obvious structural
damage. The joint area is usually warm and the
temperature elevated by between 3 to 6° Celsius [7]. In the
first three weeks of acute Charcot foot there are normally
no changes seen on X-ray [7]. During later stages of Char-
cot foot radiographic investigation may reveal some evi-
dence of dislocation or fracture of the foot [8].
Diabetes mellitus and depression are recognised as
two of the most important public health issues in the
UK and elsewhere. Major reviews of cross-sectional data
argue that as a rule of thumb diabetes increases the risk
of depression 2-fold compared to those without diabetes
[9,10]. However, absolute figures vary as function of type
of assessment with questionnaire studies reporting twice
the prevalence compared to studies based on psychiatric
interviews. This difference has also been observed in
non-diabetic populations; the prevalence of depressive
disorders in non-diabetic comparison groups, as assessed
by full diagnostic interview, has been reported as 5% in aral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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have profound consequences for individuals and society
[11]. Anxiety can manifest itself in a variety of overlap-
ping neurotic disorders including generalised anxiety
disorder, phobias, obsessive-compulsive disorder, post-
traumatic stress disorder and panic disorder [12]. Anxiety
symptoms are more common in patients with diabetes
compared to those without [13].
Psychological comorbidity confers additional risks on
patients with diabetes resulting in poorer self-care and
poorer outcomes [14]. Depression in type 2 diabetes has
been shown to be associated with twice the rate of a first
diabetic foot ulcer over a 4 year follow-up period [15]
and higher rates of amputation [16]. In addition depres-
sion in first diabetic foot ulcer is associated with a two-
fold increase of mortality over 5 years [17].
In patients with diabetes, both depression and anxiety
levels have been demonstrated to be higher in those with
chronic foot ulceration than in controls [18]. For anxiety,
it has been argued that its links with self-care and clinical
diabetes outcomes are less clear compared to those of de-
pression; dependent on the nature of the anxiety problem,
poorer or even enhanced self-care may be envisaged [19].
Existing research has not focused on psychological
morbidity in patients specifically with diabetic Charcot
foot. Ulcerations and Charcot foot have either been
grouped together [20] or Charcot foot is not mentioned
as a distinct diagnosis [21]. Existing studies are based on
small groups of Charcot patients, but findings specific to
this group are not presented in publications [22]. Foot
ulceration is much more common than Charcot foot in
diabetes; thus it is not unusual to recruit samples which
exclude patients with Charcot foot [15,23]. The severity
of foot problems in diabetes has been addressed in quali-
tative research, but only in persons with a diabetic foot
ulcer rather than with Charcot foot again suggesting that
the latter condition has not been studied specifically in
qualitative research either: ‘When you stop to think about
it [the ulcer] you could just get up and go and now you
can’t; you’re restricted; you have to take care not to knock
your leg; you have to be careful that you don’t tread on
anything that you know is on the ground.‘ In the same
paper a male having lost his job consequent to ulcer-
ation is quoted: ‘I would lose my life as well. In fact I
think I did.’ [24]. Whether ulceration or Charcot foot is
worse, is an open question. However, it is clear that very
limited data is available on mental health in patients
with diabetes and Charcot foot.
Thus, the aim of the present paper is twofold: (i) to re-
port on mental health on the basis of HADS scores
(anxiety and depression symptoms) in patients with
diabetes and Charcot foot and (ii) to compare our find-
ings with HADS comparison data in patients with dia-
betes with and without complications. We shall reportfull details on our patient group with diabetes and
Charcot foot, as the authors are not aware of any recent
study specifically recruiting patients with diabetes and
Charcot foot.
Methods and patients
A cross-sectional questionnaire survey was carried out. A
group of patients with a confirmed diagnosis of diabetes
with Charcot foot were recruited from a tertiary care facil-
ity in South London (King’s College Hospital) between
March 2010 and July 2010. King’s College Hospital dia-
betic foot clinic is a referral centre for diagnosis and treat-
ment of Charcot foot as well as a variety of other serious
foot complications. The main treatment offered for Char-
cot foot is a total contact cast to stabilise and off load
pressure from joints and foot. All patients were recruited
from the same clinic waiting area; assistance was provided
as and when necessary (e.g. questions were read out to in-
dividuals with impaired vision).
Data on anxiety and depression were collected by
means of the validated and widely used Hospital Anxiety
and Depression Scale (HADS) [25]. A major advantage
of this scale is that it carries a lower risk of confounding
diabetes-related and psychological morbidity symptoms
compared to some other widely used scales. The internal
consistency reliabilities of the HAD sub-scales were
calculated using Cronbach’s alpha coefficient. Alpha
coefficients for anxiety and depression were 0.86 and
0.78 respectively, indicating good reliability. HADS data
were initially analysed using standard classifications:
the HADS scores for anxiety and depression were cate-
gorised into three groups: scores 0-7 “no risk”, 8-10
“borderline risk of anxiety or depression” and scores of
≥11 as intermediate or severe risk of anxiety or depres-
sive (“intermediate risk” for short). In addition, anxiety
and depression scores were dichotomised using the fol-
lowing cut points: a score between 0 and 7 was classed
as normal and a score between 8 – 21 points as in-
creased risk. Diabetes related information and demo-
graphics were provided by patients on a self-designed
recording sheet: patient age at time of recruitment, gen-
der, self-reported ethnicity, marital status (married/co-
habiting, separated/divorced, single, other), occupational
status and the foot site affected by Charcot.
The case definition for Charcot foot was: (1) diagnosis
by an expert clinician with a confirmed date of diagnosis;
(2) Charcot was located in the anatomical foot. Exclusion
criteria were any active foot ulceration or amputation,
learning disability, inability to read and write in English,
pregnancy or lactation, and other significant acute or
chronic illnesses. Patients currently receiving psychoactive
drugs or psychiatric treatment were excluded because
these treatments would be expected to considerable im-
prove anxiety and depression levels and therefore lead to
Table 1 Descriptive information for Charcot sample
(n = 50) (mean ± SD; n and percentages)
Variable Mean ± SD
or n (%)
Mean
Anxiety
Mean
Depression
Score ± SD Score ± SD
Female 19 (38%) 8.4 ± 4.0** 7.6 ± 3.4♯
Male 31 (62%) 5.1 ± 4.2 5.6 ± 3.5
Age (years) 62.2 ± 8.5
≤ 60 years 24 (48%) 6.8 ± 4.3 6.8 ± 3.7
61 + years 26 (52%) 6.0 ± 4.5 5.9 ± 3.5
White 38 (76%) 5.8 ± 4.3♯ 5.7 ± 3.4*
Non—white (BME) 12 (24%) 8.3 ± 4.1 8.4 ± 3.4
Working 11 (22%) 5.8 ± 4.2 4.4 ± 4.1*
Not working 39 (78%) 6.5 ± 4.5 6.9 ± 3.3
Married 27 (54%) 6.8 ± 4.3 7.0 ± 3.5
Single or divorced 23 (46%) 5.9 ± 4.5 5.5 ± 3.5
Duration of diabetes (years) 20.6 ± 10.3
≤ 17 years 25 (50%) 6.4 ± 4.4 6.4 ± 4.5
18 + years 25 (50%) 6.1 ± 3.7 6.6 ± 3.5
Duration of Charcot foot (years) 5.0 ± 3.4
≤ 4 years 24 (48%) 6.7 ± 4.2 6.2 ± 3.7
5 + years 26 (52%) 6.1 ± 4.6 6.5 ± 3.5
Charcot site:
Ankle joint only 9 (18%) 6.4 ± 3.7 6.4 ± 2.7
Mid-foot only 28 (56%) 6.0 ± 4.3 6.6 ± 3.8
Fore-foot only 8 (16%) 6.0 ± 5.5 5.6 ± 4.8
Ankle and Mid-foot (n = 3)/
Mid- and fore-foot (n = 2)
5 (10%) 8.8 ± 4.8 5.8 ± 1.5
Mean ± SD for anxiety and depression scores.
♯p < 0.10, *p ≤ 0.05 **p ≤ 0.01.
Table 2 Mental health (HADS) scores –means and risk levels
HAD Scale Mean ± SD Normal score
≤7 n (%)
Borderline risk
8–10 n (%)
Intermediate
risk ≥11 n (%)
Anxiety 6.4 ± 4.4 29 (58%) 12 (24%) 9 (18%)
Depression 6.3 ± 3.6 29 (58%) 14 (28%) 7 (14%)
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with Charcot foot.
Ethical approval was obtained from University of
Roehampton, King’s College Hospital NHS Foundation
Trust and Outer North London Research Ethics Committee
(REC Ref No 10/HO724/8). Participants provided in-
formed consent.
Statistical analysis
Data were checked and analysed using Microsoft Excel and
SPSS V20. Frequencies and percentages were calculated.
Normality assumptions for the HADS scales were not vio-
lated (Kolmogorov-Smirnov test p-values >0.10). Means
and standard deviations (mean ± SD) are reported for
scaled data, but where the focus is on differences or the
comparison with reference data (see below) we used 95%
confidence intervals. We chose this form of presentation to
provide the most relevant information to the reader (stand-
ard deviations and confidence intervals can be mutually
transformed if relevant sample sizes are provided as we
did). Anxiety and depression scores were analysed using
dimensional scale scores and also as grouped data, after
converting scale scores into 2 or 3 risk categories (full
details in results section). Bi-variate comparisons used
t-tests. Comparisons with published data from Collins
et al. [26] will be used as a key point of reference as far as
possible; we refer to these data as the reference data. Their
relatively large population sample of 1456 patients (general
practice and out-patients from the Republic of Ireland) in-
cludes 296 patients with type 1 diabetes; both bi- and
multi-variate results do not suggest an effect of type of dia-
betes on anxiety or depression scores. It is therefore justi-
fied to carry out the comparisons with these reference data
(this approach is supported by Perry as the senior author
of the paper, personal communication, 2013) [26]. All ana-
lyses using SPSS applied bootstrap methods to minimise
potential problems associated with non-normality and the
relatively small Charcot patient group of n = 50. Signifi-
cance was set at p ≤ 0.05; whenever statistical associations
or differences are discussed, they are significant (unless
stated otherwise). Full details on statistical findings are
provided in tables and figures.
Results
Patient characteristics
The participants were predominantly male (31 males and
19 females) with a mean age of 62 years. Data on marital
status, work status and ethnicity and other sample charac-
teristics are provided in Table 1. The most common site
of Charcot foot problems was the mid-foot (54%).
Mental health: anxiety and depression
Anxiety and depression scores for the total sample are
presented in Table 2. Results are also presented in termsof risk categories: normal risk, borderline risk and inter-
mediate risk which includes a small number of patients
who are severe risk. In total, increased risk levels have been
found for 42% of patients, both for anxiety and depression.
Mental health and demographics
Female patients experience significantly higher levels of
anxiety and depression. Full details can be found in
Table 1. Age is not correlated with anxiety or depression
scores (p-values >0.50). Following dichotomisation of age
into those up to 60 years old and those older than 60, both
anxiety and depression scores are lower for the older
group, but the differences did not reach significance.
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white patients, ethnicity was grouped in terms of white
versus Black Minority Ethnicity (BME) patients. The
number of BME patients with Charcot foot was 12 out
of 50 (24%). Patients with a BME background had sig-
nificantly higher depression scores, but differences for
anxiety only reached borderline significance (p < 0.10)
(see Figure 1). Patients in work reported lower levels of
depression scores compared to those not working, but
no difference was observed for anxiety scores. Marital
status (married vs single or divorced) was not associated
with levels of anxiety or depression scores.
Duration of diabetes and Charcot foot
The mean duration of diabetes was 20.6 (SD= 10.3 years).
The mean duration of Charcot foot was 5.0 years (SD= 3.4).
Correlations between duration of Charcot foot and anxiety(a)
(b)
Figure 1 Risks of anxiety and depression in White people with
diabetes and Charcot foot compared to those from Black
Minority Ethnic groups (frequency counts ± 95% CI). The
difference for anxiety risk is not significant (p ≤ 0.10), but the
difference for depression is significant (p ≤ 0.05).(r50 = 0.23, p = 0.11) and depression scores (r50 = 0.08,
p = 0.59) were weak and did not reach significance. We
also dichotomised these time-defined variables using
the median split. Differences in anxiety and depression
scores in relation to diabetes duration (up to 17 years
vs longer) and Charcot foot duration (up to 4 years vs
longer) were very small and did not reach significance
(see Table 1).
Comparisons with published HADS data
Results from a major study on patients with diabetes
[26] using the HADS and carried out in Ireland included
a sample of n = 1,456 patients with diabetes, of which
1,291 and 1,308 individuals provided anxiety and depres-
sion data respectively. Re-‐analysis of the published data
produced a prevalence of 29% for increased anxiety risk
and 22% for increased depression risk for type 2 diabetes
patients, after excluding those with type 1. Table 3 pro-
vides estimated odds ratios and 95% confidence inter-
vals. The odds are 1.8 for anxiety and 2.5 for depression,
indicating that our sample of patients with diabetes and
Charcot foot is exposed to a significantly increased risk
of mental health problems compared to a large diabetes
reference sample (p < 0.05).
Collins et al. [26] reported considerable detail regard-
ing demographics and diabetes related characteristics.
Comparisons by gender and diabetes complications were
carried out. However, for this analysis the published data
do not allow for the separation of type 1 and type 2 pa-
tients which is not a serious problem given that anxiety
and depression levels were comparable for both groups
(see also data analysis section). Comparisons of Collins
et al.’s data with our Charcot sample can be found in
Figure 2. Statistical results are based on one sample t-tests
with Collin’s paper providing reference values. HADS
scores are higher for both males and females in the
Charcot foot sample compared to the reference sample
data (p < 0.05). Also we compared their means and SDs
for people with diabetes with no complication, one
complication or 2 and more complications with our
sample with Charcot foot. Figure 3 shows the results.
The HADS scores for the Charcot sample are higher
than for all groups in the reference sample, including
those with 2 or more complications.
Discussion
High levels of anxiety and depression scores and a high
prevalence of being at risk of mental health problems were
observed in our sample of 50 diabetes patients with Charcot
foot. Incidentally the figures are exactly the same for anxiety
and depression risks. The literature on mental health
in diabetes focuses on depression and only limited data
is available on anxiety levels and risks. Comparisons with
findings on depression from meta–analyses of general
Table 3 Anxiety and depression risk in the diabetes reference sample and the Charcot foot sample
Diabetes sample n Charcot sample n Odds ratio CI p-value
Anxiety Normal 779 (71%) 29 (58%)
Increased Risk 315 (29%) 21 (42%) 1.79 1.006 - 3.188 0.048*
De-pression Normal 805 (78%) 29 (58%)
Increased Risk 233 (22%) 21 (42%) 2.50 1.401 - 4.469 0.002**
*p ≤ 0.05; **p ≤ 0.01.
(a)
(b)
Figure 2 Mean scores ± 95% confidence intervals for (a) anxiety scores and (b) depression scores. Bars present findings for males and
females for Charcot sample and diabetes reference sample. Stars indicate significance level of p based on bi-variate tests (★ p ≤ 0.05, ★★
p ≤ 0.01, ★★★ p ≤ 0.001). For full details of tests see text.
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(a)
(b)
Figure 3 Comparison between Charcot sample and reference data of diabetes patients without, with 1 and with 2 or more
complications (diabetes sample) for (a) anxiety and (b) depression scores. Means ± 95% CI. Stars indicate significance level of p based on
bi-variate tests (★★★ p≤ 0.001). For full details of tests see text.
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prevalence for depression risk is double that of around
20% which is typically found for general diabetes
samples.
Statistical comparisons with findings from a study which
used the HADS in a large sample of diabetes patients
(with and without complications) again support the view
that diabetes patients with Charcot foot are at a consider-
ably increased risk of anxiety and depression. Further
comparisons with this data set on the basis of the number
of complications shows that diabetes patients with Char-
cot foot have significantly higher depression scores thandiabetes patients which have 2 or more complications.
The figures for anxiety show similar patterns (P <0.10).
While we did not collect data on the number of complica-
tions in our sample, the trends clearly show that patients
with Charcot foot experience high levels of anxiety and
depression symptoms. We accept that it is possible or
likely that patients in this study are likely to suffer from
other complications; this is typical for most studies focus-
ing on advanced complications of diabetes. These add-
itional complications may affect mental health and
wellbeing and are of conceptual interest, but for the prac-
titioner it is important to note that patients with Charcot
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plications, do suffer from very high levels of depression
and to a lesser extent from increased anxiety compared to
those patients from our reference sample who have 2 or
more complications (26).
Demographic characteristics are linked to mental
health in this sample of Charcot patients. Women suffer
higher anxiety and depression levels, and members of
BME groups and people out of work suffer higher de-
pression levels, but differences for anxiety do not reach
significance. Higher levels of anxiety and depression in
females are in line with general trends in population
samples [27]. Interestingly differences between the gen-
ders are more pronounced in the Charcot sample com-
pared to the general diabetes sample.
Higher depression levels in BME patients and patients
out of work are not unexpected and are likely to reflect
greater vulnerability to mental health issues [28]. Marital
status is unrelated to mental health, but it is perhaps
surprising that single or divorced patients report lower,
but statistically non-significant, scores. No associations
were found between mental health and disease duration.
HADS data were also reported in a study by Boulton
and his colleagues in Manchester (UK) [18] on patients
with chronic foot ulceration and matched diabetes con-
trols (n =13 and 26 respectively). These authors reported
median scores and ranges only for the combined HAD
scale (sum of anxiety and depression score): for ulcer-
ation the median = 9 (range O-16) and controls the
median = 4 (O-26). We calculated the same statistic for
the two groups in our study: medians for the entire
HAD scale were 14 (0 – 28) for the patients with
Charcot foot and 14 (0 – 34) in the comparison group.
Our values are considerably higher than those observed
by Boulton and colleagues (statistical significance could
not be determined for this comparison, due to insuffi-
cient data provided in the paper).
This paper presents possibly the first study addressing
mental health problems specifically in a sample of dia-
betes patients with Charcot foot. Another strong point is
the use of the HADS scale which carries a lower risk of
confounding symptoms of anxiety and depression with
symptoms due to diabetes. The PHQ-9 questionnaire
which is widely used for the assessment of depression
risk, in contrast, contains items which assess symptoms
common to depression and diabetes [29].
The Charcot patients were carefully identified and
confounding with other acute foot problems was kept to
a minimum. It needs to be remembered that Charcot
foot is a rare condition with an incidence rate of 0.3%
per year for a large diabetes clinic in Denmark [30]. Also
all patients were recruited from the same specialist ter-
tiary care centre, facilitating the recruitment of a sizable
sample. The instrument for assessing psychologicalmorbidity, i.e. the HADS, is one of the most widely used
questionnaires for screening and risk assessment for
anxiety and depression. It is accepted that a psychiatric
diagnostic interview [31] would have been preferable but
was not practicable for this study. Future research may
also want to consider collecting more details on the his-
tory of foot problems and a detailed assessment of the
severity of the current state of the Charcot foot, either
by clinician judgement or using a system comparable to
the Wagner or Texas classification systems [32].
There are currently no other studies available examining
the mental health status in patients with Charcot foot
which would allow direct comparisons with our findings.
However there are two studies which have looked at
health status using the SF-36 questionnaire in patients
with Charcot foot [33,34]. They both found that the so-
called ‘physical health component summary scores’ (PCS),
which is a measure of physical healthstatus, were lower in
patients with Charcot foot when compared to general
population data, indicating not surprisingly poorer health
status in the Charcot group. Interestingly both papers re-
ported that the so-called ‘mental component summary
scores’ (MCS) which cover aspects of mental health were
not different in patients with Charcot foot compared to
the general population [33,34]. In addition the mean men-
tal and physical component summaries were not affected
by gender, ethnicity and Charcot stage [33]. However, nei-
ther of the studies assessed anxiety and depression levels;
we interpret these negative findings as reflecting the lack
of suitability of the SF-36 as an instrument for adequately
assessing mental health in this group of individuals.
Conclusion
Anxiety and depression problems are more severe and
more common in diabetes patients with Charcot foot. Fe-
male gender, being a member of a BME group and out of
work carry additional risks. While problems around
depressive symptoms are widely discussed in the general
diabetes literature, anxiety is possibly insufficiently recog-
nised. In our sample anxiety scores were particularly high
for females. Given the poor outcomes in patients with dia-
betes and co-morbid depression [14] and the availability
of effective psychological interventions for patients with
diabetic foot complications [35], it is important to prevent
and treat depression, and to review guidelines accordingly.
Whether the same applies to anxiety, cannot be asserted
without further studies, but similarly to depression, effect-
ive treatments exist for anxiety problems and are provided
in the UK through the Improving Access to Psychological
Therapies services [36]. Clinician awareness of the high
risk of anxiety and depression in these mostly older and
vulnerable adults [37,38] should guide appropriate screen-
ing and care planning including access to psychological
support, hopefully resulting in better outcomes.
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